MTD Mettler Toledo

FY2025 10-K
Filed: Feb 6, 2026
Health Care
Laboratory Analytical InstrumentsSEC EDGAR

Mettler Toledo (MTD) filed its fiscal year 2025 10-K annual report with the SEC on Feb 6, 2026. This page provides AI-powered analysis of the filing, including business overview, management discussion, risk factors, and key financial metrics from XBRL data.

AI Filing Analysis
FY2025 10-K

Business Overview

  • Core business: Precision instruments and analytical equipment manufacturing for laboratory and industrial use
  • New share repurchase program authorization of $2.75 billion in November 2025, adding to $3.7 billion remaining availability
+3 more insights

Management Discussion & Analysis

  • Revenue $4.0B in 2025, up 4% YoY from $3.9B in 2024; local currency sales up 3% in 2025 and 2024
  • Gross margin 59.4% in 2025 vs 60.1% in 2024; product margin 61.1% vs 62.1%, service margin 54.4% vs 53.7%
+3 more insights

Risk Factors

  • U.S.-China geopolitical tensions causing 16% sales, 29% segment profit, 29% production exposure in China with tariff increases and supply chain risks
  • Ukraine war and Middle East conflict disrupting supply chains, increasing costs, reducing shipping capacity, and heightening global economic uncertainty
+3 more insights

Financial Summary
XBRL

Revenue

$4.0B

Net Income

$869M

Gross Margin

59.4%

Net Margin

21.6%

ROE

-3677.4%

Total Assets

$3.7B

EPS (Diluted)

$42.05

Operating Cash Flow

$956M

Source: XBRL data from Mettler Toledo FY2025 10-K filing on SEC EDGAR. All figures in USD.

Get deeper insights on Mettler Toledo

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.

Try Pro free for 1 month!

Enter SX-8KKYTN at checkout

Limited spots available